A significant difference was determined in allele frequencies of XRCC1 rs25487, XRCC3 rs861539, XPG rs17655 and hMSH2 rs4987188 between BC patients and controls (p = 0.001, respectively). This evidence concerns the gene MSH2 and breast cancer.